Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

MedImmune Inc.

(MEDI), Gaithersburg, Md.

Business: Infectious diseases, Transplant

SG Cowen analyst Philip Nadeau lowered his 2002

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE